Evidence map›Paper›PMID 26650067›Full record

ArticleJournal of neuro-oncology2016

Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.

Anthony Pham, Menachem Z Yondorf, Bhupesh Parashar, Ronald J Scheff, Susan C Pannullo, Rohan Ramakrishna, Philip E Stieg, Theodore H Schwartz, A Gabriella Wernicke

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Revisiting the Role of Surgical Resection for Brain Metastasis.Brain tumor research and treatment · 2023
    Review
  10. Review
  11. Article
  12. Brachytherapy for central nervous system tumors.Journal of neuro-oncology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Placement ofJournal of contemporary brachytherapy · 2019
    Article
  20. Biodegradable seeds of holmium don't change neurological function after implant in brain of rats.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anthony PhamWeill Cornell Medical College, New York, NY, USA.
Menachem Z YondorfNew York-Presbyterian/Weill Cornell Medical Center, New York, NY, USA.
Bhupesh ParasharNew York-Presbyterian/Weill Cornell Medical Center, New York, NY, USA.
Ronald J ScheffDepartment of Medical Oncology, Brain and Spine Center, Weill Cornell Medical College/NewYork-Presbyterian Hospital, 525 E. 68th Street, Starr 651, Box 99, New York, NY, 10065, USA.
Susan C PannulloDepartment of Neurosurgery, Brain and Spine Center, Weill Cornell Medical College/NewYork-Presbyterian Hospital, 525 E. 68th Street, Starr 651, Box 99, New York, NY, 10065, USA.
Rohan RamakrishnaDepartment of Neurosurgery, Brain and Spine Center, Weill Cornell Medical College/NewYork-Presbyterian Hospital, 525 E. 68th Street, Starr 651, Box 99, New York, NY, 10065, USA.
Philip E StiegDepartment of Neurosurgery, Brain and Spine Center, Weill Cornell Medical College/NewYork-Presbyterian Hospital, 525 E. 68th Street, Starr 651, Box 99, New York, NY, 10065, USA.
Theodore H SchwartzDepartment of Neurosurgery, Brain and Spine Center, Weill Cornell Medical College/NewYork-Presbyterian Hospital, 525 E. 68th Street, Starr 651, Box 99, New York, NY, 10065, USA.
A Gabriella WernickeNew York-Presbyterian/Weill Cornell Medical Center, New York, NY, USA. gaw9008@med.cornell.edu.
New York Hospital Queens · USPresbyterian Hospital · USCornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraoperative permanent Cesium-131 (Cs-131) brachytherapy can provide a viable alternative to WBRT with excellent response rates and minimal toxicity. This study reports the results of the prospective trial of the impact of intraoperative Cs-131 on neurocognitive function and quality of life (QoL) in patients with resected brain metastases. Between 2010 and 2012, 24 patients with newly diagnosed metastasis to the brain were accrued on a prospective protocol and treated with Cs-131 brachytherapy seeds after surgical resection. Physicians administered the mini-mental status examination (MMSE) and functional assessment of cancer therapy-brain (FACT-Br) questionnaire to all patients before treatment and again every 2 months for the duration of 6 months with additional follow-up again at 12 months. Wilcoxon rank sum test was used to analyze statistically significant changes in MMSE over time and paired t test was used to analyze changes in FACT-BR. There was a statistical improvement in overall FACT-BR score at 4 and 6 months of follow-up when compared to baseline (162 vs. 143, P = 0.004; 164 vs. 143, P = 0.005 respectively) with a non-significant trend toward improvement at 2 and 12 months (154 vs. 143, P = 0.067; 159 vs. 149, P = 0.4). MMSE score was statistically improved at 4 and up to 12 months compared to pre-treatment MMSE (30 vs. 29, P = 0.017; 30 vs. 29, P = 0.001 respectively). Patients with brain metastasis who received intra-operative permanent Cs-131 brachytherapy implants saw an improvement of their neurocognitive status and self-assessment of QoL. In addition to the excellent local control of metastasis, this approach may contribute to the improvements in cognitive function and QOL.

Indexed as

BrachytherapyCranial IrradiationQuality of LifeAgedAged, 80 and overBrain NeoplasmsCesium RadioisotopesCognitionFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesCesium RadioisotopesBrachytherapyCesium-131 (Cs-131)Cognitive functionMetastasesQuality of lifeRadiationRadiotherapy

Identifiers

PMID26650067
OpenAlexW2191442846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.